GrowthWorks Capital logo

GrowthWorks Capital

North America, British Columbia, Canada, Vancouver

Description

GrowthWorks Capital is a Vancouver-based venture capital firm focused on the management of regionally-based venture capital funds.

Investor Profile

GrowthWorks Capital has made 65 investments, with 0 in the past 12 months and 5% as lead.

Stage Focus

  • Series Unknown (26%)
  • Series C (22%)
  • Series B (22%)
  • Series A (17%)
  • Series D (12%)
  • Series E (2%)

Country Focus

  • Canada (75%)
  • United States (22%)
  • United Kingdom (2%)
  • Denmark (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Software
  • Biopharma
  • Electronics
  • Medical
  • Pharmaceutical
  • Telecommunications
  • Manufacturing
  • Internet
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GrowthWorks Capital frequently co-invest with?

Ventures West
North America, British Columbia, Canada, Vancouver
Co-Investments: 10
Domain Associates
North America, California, United States, San Diego
Co-Investments: 3
Chrysalix Venture Capital
North America, British Columbia, Canada, Vancouver
Co-Investments: 3
OVP Venture Partners
North America, Washington, United States, Seattle
Co-Investments: 4
BDC Venture Capital
North America, Alberta, Canada, Calgary
Co-Investments: 23
Business Development Bank of Canada
North America, Quebec, Canada, Montréal
Co-Investments: 7
Yaletown Partners
North America, British Columbia, Canada, Vancouver
Co-Investments: 9
Quaker BioVentures
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 3
MDS Capital
North America, New York, United States, New York
Co-Investments: 5
VenGrowth Asset Management
North America, Ontario, Canada, Toronto
Co-Investments: 5

What are some of recent deals done by GrowthWorks Capital?

Spotta

Cambridge, Cambridgeshire, United Kingdom

Spotta is the creator of an ultra-low-power insect monitoring sensor meant to identify bed bug infestations.

HospitalityHousekeeping ServicePet
Series ADec 15, 2023
Amount Raised: $3,807,000
SWITCH Materials

Burnaby, British Columbia, Canada

SWITCH Materials develops new materials based on proprietary organic particles for the areas of molecular electronics and health sciences.

ElectronicsHealth CareOrganic
Series CJun 24, 2015
Amount Raised: $2,954,521
General Fusion

Richmond, British Columbia, Canada

General Fusion develops commercial fusion energy using Magnetized Target Fusion technology.

EnergyEnvironmental EngineeringRenewable Energy
Series UnknownMay 19, 2015
Amount Raised: $22,134,685
BuildDirect

Vancouver, British Columbia, Canada

BuildDirect provides an online marketplace for buying and selling building materials.

Building MaterialE-Commerce PlatformsHome ImprovementMarketplace
Series CDec 10, 2014
Amount Raised: $50,000,000
BTI Systems

Ottawa, Ontario, Canada

BTI Systems is a software and networking company delivering solutions for service and content providers.

Cloud ComputingSoftwareTelecommunications
Series DJan 7, 2014
Amount Raised: $27,000,000
INETCO Systems Limited

Burnaby, British Columbia, Canada

INETCO provides payment fraud detection, transaction monitoring and channel analytics solutions for banking and payments environments.

AnalyticsFinTechFraud DetectionSoftware
Series UnknownJul 1, 2013
Amount Raised: $250,000
Ambit Biosciences

San Diego, California, United States

Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.

BiopharmaBiotechnologyHealth Care
Series UnknownNov 6, 2012
Amount Raised: $50,000,000
D-Wave Systems

Burnaby, British Columbia, Canada

D-Wave Systems designs and manufactures quantum computing and superconducting electronics.

ElectronicsManufacturingQuantum ComputingSemiconductor
Series UnknownOct 4, 2012
Amount Raised: $30,000,000
GenoLogics

Victoria, British Columbia, Canada

GenoLogics provides biomedical solutions and data management software, advancing the early detection, prevention, and treatment of diseases.

BiotechnologyData ManagementHealth CareSoftware
Series DFeb 10, 2012
Amount Raised: $8,000,000
MSI Methylation Sciences

Burnaby, British Columbia, Canada

MSI Methylation Sciences is a biotechnology company that develops and markets S-Adenosyl Methionine.

BiotechnologyDietary SupplementsMedicalTherapeutics
Series ASep 29, 2011
Amount Raised: $18,369,921